Aviance Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-146
| Closed | -$486K | – | 322 |
|
|
2014
Q4 | $486K | Buy |
146
+17
| +13% | +$56.6K | 0.02% | 234 |
|
|
2014
Q3 | $373K | Buy |
129
+20
| +18% | +$57.8K | 0.02% | 250 |
|
|
2014
Q2 | $413K | Buy |
109
+9
| +9% | +$34.1K | 0.02% | 240 |
|
|
2014
Q1 | $543K | Buy |
100
+97
| +3,233% | +$527K | 0.03% | 198 |
|
|
2013
Q4 | $9K | Buy |
+3
| New | +$9K | ﹤0.01% | 365 |
|